Article Type
Changed
Fri, 06/03/2022 - 11:22
Display Headline
Pediatric Dermatology: Summer 2017

An editorial supplement to Pediatric News and Dermatology News

Articles include:

  • Pivotal dupilumab results for eczema create a sensation
  • Fight back against psoriasis bullies
  • Monthly lab testing for isotretinoin? No need
  • Consider all acne in Latinos inflammatory
  • Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
  • And more …

Faculty:

Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.

Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

 

Publications
Sections

An editorial supplement to Pediatric News and Dermatology News

Articles include:

  • Pivotal dupilumab results for eczema create a sensation
  • Fight back against psoriasis bullies
  • Monthly lab testing for isotretinoin? No need
  • Consider all acne in Latinos inflammatory
  • Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
  • And more …

Faculty:

Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.

Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

 

An editorial supplement to Pediatric News and Dermatology News

Articles include:

  • Pivotal dupilumab results for eczema create a sensation
  • Fight back against psoriasis bullies
  • Monthly lab testing for isotretinoin? No need
  • Consider all acne in Latinos inflammatory
  • Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
  • And more …

Faculty:

Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.

Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

 

Publications
Publications
Article Type
Display Headline
Pediatric Dermatology: Summer 2017
Display Headline
Pediatric Dermatology: Summer 2017
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Off
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article